A Randomized Trial to Assess Catheter Ablation versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure (ARC-HF) ONLINE FIRST
Clinical Trials Thursday, March 14th, 2013JACC: March 1, 2013
Objectives To compare catheter ablation with rate-control for persistent atrial fibrillation (AF) in heart failure (HF).
Background The optimal therapy for AF in HF is unclear. Drug-based rhythm-control has not proved clinically beneficial. Catheter ablation improves cardiac function in patients with HF, but impact on physiological performance has not been formally evaluated in a randomized trial. Read more
